Market: NMS |
Currency:
Address:
📈 LIFE Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$20.25
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
16
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
50-100%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for LIFE
| Date | Reported EPS |
|---|
| 2026-02-25 | 0.42 |
| 2024-05-29 | -0.23 |
| 2024-03-15 | -0.23 |
| 2024-02-09 | -0.25 |
| 2023-10-03 | -0.2 |
| 2023-07-19 | -0.22 |
| 2023-04-17 | -0.29 |
| 2023-03-03 | -0.26 |
| 2022-09-13 | -0.46 |
| 2022-07-21 | -0.44 |
| 2022-04-12 | -0.44 |
| 2021-11-11 | -0.31 |
| 2021-10-12 | -0.42 |
| 2021-05-14 | -0.64 |
| 2021-05-10 | -0.51 |
| 2021-03-16 | -0.47 |
| 2020-10-30 | -0.68 |
| 2020-06-26 | -0.69 |
| 2020-04-28 | 0.25 |
| 2020-03-04 | -1.54 |
| 2019-11-05 | -1.47 |
| 2019-07-02 | -1.8 |
| 2019-03-30 | -2.52 |
| 2019-02-01 | -2.94 |
| 2018-10-08 | -3.36 |
📰 Related News & Research
-
Kezar Life Sciences Announces Lease Termination and Executive Separation Agreements in April 2026
April 4, 2026
Kezar Life Sciences Announces Entry into Merger Agreement wi...
-
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal
April 4, 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences: Key ...
-
RCM Technologies, Inc. Company Overview: Specialty Healthcare, Engineering, and Life Sciences Solutions & Growth Strategies
April 4, 2026
RCM Technologies, Inc. Files Annual Report: Key Details for ...
-
F&G Annuities & Life, Inc. 8-K Filing Details: Company Info, Securities, and NYSE Listings
April 2, 2026
F&G Annuities & Life, Inc. Adopts Share Repurchase Plan Unde...
-
iSpecimen Marketplace: Transforming Biospecimen Procurement with Innovative Technology Solutions for Life Science Research
April 2, 2026
iSpecimen Inc. 2025 Annual Report: Key Investor Highlights a...
-
FitLife Brands, Inc. 2025 Financial Performance: Online & Wholesale Revenue, Margins, and Strategic Initiatives
April 1, 2026
FitLife Brands, Inc. Reports Fiscal Year 2025 Financial Resu...
-
Synergy CHC Corp: Growth Strategy, Competitive Strengths, and Market Expansion in Consumer Health, Beauty, and Lifestyle Products
April 1, 2026
Synergy CHC Corp. 2025 Annual Report: Key Highlights and Inv...
-
Parkway Life REIT Appoints Liquidator for Voluntary Liquidation of Wholly-Owned Subsidiary in Malaysia 1
April 1, 2026
Parkway Life REIT Announces Voluntary Liquidation of Malaysi...
-
IHH Healthcare Announces Voluntary Winding Up of Parkway Life Malaysia Sdn Bhd in 2026
April 1, 2026
IHH Healthcare Announces Member's Voluntary Winding Up of Pa...
-
Singapore Market Outlook April 2026: Seatrium, Yangzijiang, Manulife US REIT & Key Stock Updates – Maybank Research Insights 1
April 1, 2026
Broker: Maybank Research Pte Ltd Date of Report: 1 April 202...
🔍 View more Reports
